Literature DB >> 15570574

Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.

P Vandel, D Sechter, E Weiller, N Pezous, F Cabanac, A Tournoux, E Panconi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15570574     DOI： 10.1002/hup.644

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN： 0885-6222            Impact factor:   1.672


× No keyword cloud information.
  5 in total

Review 1.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

Review 2.  Milnacipran versus other antidepressive agents for depression.

Authors:  Atsuo Nakagawa; Norio Watanabe; Ichiro M Omori; Corrado Barbui; Andrea Cipriani; Hugh McGuire; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

3.  Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression.

Authors:  Kunitoshi Kamijima; Shinji Hashimoto; Eiichi Nagayoshi; Tsukasa Koyama
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-26       Impact factor: 2.570

4.  Milnacipran: a unique antidepressant?

Authors:  Siegfried Kasper; Gerald Pail
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

5.  Why does milnacipran produce so few discontinuation syndromes following abrupt withdrawal?

Authors:  Fumihiko Okada
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.